UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment

Molecular cancer therapeutics, 2004-12, Vol.3 (12), p.1505-1512

2004

Volltextzugriff (PDF)

A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate

International journal of nanomedicine, 2024-01, Vol.19, p.307-326

2024

Volltextzugriff (PDF)

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors

Cancer, 2019-07, Vol.125 (14), p.2409-2422

2019

Volltextzugriff (PDF)

Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels

Molecular medicine (Cambridge, Mass.), 2002-08, Vol.8 (8), p.475-486

2002

Volltextzugriff (PDF)

HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents

Annals of the New York Academy of Sciences, 2003-12, Vol.1002 (1), p.78-89

2003

Volltextzugriff (PDF)

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer

Cancer gene therapy, 2001-10, Vol.8 (10), p.728-739

2001

Volltextzugriff (PDF)

Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors

Molecular therapy, 2013-05, Vol.21 (5), p.1096-1103

2013

Volltextzugriff (PDF)

Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide

Nucleic acids research, 2018-02, Vol.46 (3), p.1424-1440

2018

Volltextzugriff (PDF)

Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

Clinical cancer research, 2019-05, Vol.25 (9), p.2860-2873

2019

Volltextzugriff (PDF)

scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7539

2024

Volltextzugriff (PDF)

Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor

Oncoimmunology, 2018-10, Vol.7 (10), p.e1484982-e1484982

2018

Volltextzugriff (PDF)

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

Cancer letters, 2015-12, Vol.369 (1), p.250-258

2015

Volltextzugriff (PDF)

A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival

ACS nano, 2014-06, Vol.8 (6), p.5494-5514

2014

Volltextzugriff (PDF)

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors

International journal of nanomedicine, 2024-01, Vol.19, p.5973-5993

2024

Volltextzugriff (PDF)

The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells

Molecular therapy, 2014-02, Vol.22 (2), p.278-291

2014

Volltextzugriff (PDF)

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.2938-2943

2007

Volltextzugriff (PDF)

Abstract 2164: BLID is a novel drug-inducible apoptotic molecule: Identification of an integrative mechanism of chemosensitivity in breast cancer cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2164-2164

2017

Volltextzugriff (PDF)

Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation

Molecular therapy, 2018-01, Vol.26 (1), p.84-94

2018

Volltextzugriff (PDF)

Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells In vitro and In vivo

Clinical cancer research, 2008-04, Vol.14 (7), p.2190-2198

2008

Volltextzugriff (PDF)

Antisense therapeutics: from theory to clinical practice

Pharmacology & therapeutics (Oxford), 2003-07, Vol.99 (1), p.55-77

2003

Volltextzugriff (PDF)

Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

Cancers, 2022-10, Vol.14 (20), p.5092

2022

Volltextzugriff (PDF)

Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo

Nanomedicine, 2008-12, Vol.4 (4), p.318-329

2008

Volltextzugriff (PDF)

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

Human gene therapy, 2006-01, Vol.17 (1), p.117-124

2006

Volltextzugriff (PDF)

Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue

Molecular cancer therapeutics, 2008-03, Vol.7 (3), p.559-568

2008

Volltextzugriff (PDF)

Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes

Molecular cancer therapeutics, 2002-03, Vol.1 (5), p.337-346

2002

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Humans
(28)
Animals
(22)
Mice
(20)
Female
(16)
Oncology
(14)
Liposomes
(12)
Medicine, Research & Experimental
(12)
Mice, Nude
(12)
Research & Experimental Medicine
(12)
Gene Therapy
(11)
Apoptosis
(10)
Biochemistry & Molecular Biology
(10)
Cell Line, Tumor
(10)
Tumor Cells, Cultured
(10)
Biotechnology & Applied Microbiology
(9)
Genetics & Heredity
(9)
Tumors
(9)
Xenograft Model Antitumor Assays
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antisense oligonucleotides targeted to the human α folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment

A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors

Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels

HER-2-Targeted Antisense Oligonucleotide Results in Sensitization of Head and Neck Cancer Cells to Chemotherapeutic Agents

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer

Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors

Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide

Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate

Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors

The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system

Abstract 2164: BLID is a novel drug-inducible apoptotic molecule: Identification of an integrative mechanism of chemosensitivity in breast cancer cells

Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation

Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells In vitro and In vivo

Antisense therapeutics: from theory to clinical practice

Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue

Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes

Suchergebnisse filtern